Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous ...

Vaccines are one of, if not THE most significant public health achievements. They played a pivotal role in reducing mortality from infectious diseases, once the leading causes of death. Routine ...

Related: Disease-riddled skeletons suggest leprosy and smallpox ravaged medieval German village Until now, there was no documented evidence of these changes in bone from the Americas before the ...

Emergent BioSolutions shares rose after the company disclosed that it will supply additional doses of CNJ-016, a treatment ...

About an hour after the closing bell, shares of Emergent were trading 6.4% higher, at $7.31. The company's shares ended the day's regular session at $6.87, a gain of 3.7%.

Emergent BioSolutions (EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (A ...

The suit addresses the scrapping of COVID-19 vaccination recommendations for children and pregnant women and the dismantling ...

A coalition of doctors groups and public health organizations sued the U.S. government on Monday over the decision to stop ...

I’ve always admired medical wizards who, in dire circumstances like the recent COVID-19 epidemic, somehow come up with ...

A Blueprint for Preparedness The coordinated global health effort that beat smallpox once, offers a blueprint for addressing future threats. The world has changed dramatically over the last 50 years, ...

Smallpox was eradicated in 1977. This amazing, global public health achievement isn’t just a page in a history book or an ...

The smallpox vaccine, maintained by the CDC, is freeze-dried, live vaccinia virus. It is contained in a vial of 50 doses and stored at -20 degrees C. Vaccination has been successfully administered ...